(Wed. Aug. 19 2009) avVaa World Health Care Products, Inc. Announces DRTV-Direct Response Television Media Buying Campaign for Neuroskin® Psorisis Relief Test Week With 46 Spots
LUMBY, British Columbia, avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that its DRTV-Direct Response Television advertisement test week for Neuroskin® Psoriasis Relief includes 46 individual spots on several high profile cable networks.
Lorie Campbell-Farley, President and COO of avVaa World Health Care stated, “We have approved the following 46 spots for the Neuroskin® Psoriasis Relief DRTV one week media test, beginning the week of August 24, 2009.”
These 120 second and 60 second advertisements will be seen on the following high profile cable networks:
BBC America, :60 spot, running Saturday-Sunday, 9Am-8Pm, Number of spots: 4
Biography, :120 spot, running, Monday-Friday, 8Am-2Pm, Number of spots: 4
Biography, :120 spot, running Monday-Friday, 2Pm-8Pm, Number of spots: 4
DIY, :60 spot, running Saturday-Sunday, 7Am-7Pm, Number of spots: 4
Hallmark Movie Channel, :120 spot, running Monday-Sunday, 6Pm-11Pm, Number of spots: 7
Soap Net, :120 spot, running Monday-Sunday, 12Am-6Am, Number of spots: 5
Style, :60 spot, running Monday-Sunday, 6Am-12Pm, Number of spots: 4
VH1 Classic, :120 spot, running Monday-Sunday, 2Pm-1Am, Number of spots: 7
WETV, :120 spot, running Monday-Sunday, 1Am-5Am, Number of spots: 7
Each DRTV commercial is in infomercial format, and contains an offer that urges immediate action from the viewer.
The offer is directed toward consumers looking for a steroid-free product specifically formulated to relieve the symptoms of mild to severe psoriasis, seborrheic dermatitis and other skin irritations. It will also appeal to consumers looking to break the cycle of flare ups and remissions that often lead to feelings of sadness, despair, guilt, anger and low self-esteem.
Lorie Campbell-Farley stated, “I anticipate that the DRTV test spots will bring immediate orders, both through our call centre and our web site. The cable test launch will allow us to determine which stations best target our consumers, and will also greatly enhance the overall exposure of Neuroskin Psoriasis Relief.
“Viewers are likely to view these DRTV spots as valuable and customer-oriented. Avvaa World Healthcare Products, Inc. has created a pricing structure for Neuroskin that is reasonable for consumers while generating profits for the company.”
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(r) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
CONTACT: avVaa World Health Care Products
Jack Farley, Chairman/CEO jfarley@avvaa.com
Lorie Campbell-Farley, President/COO lcfarley@avvaa.com
Investor Relations: Merle Goertz (West Coast) 1-604-688-2349
